Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Epilepsy Res ; 38(2-3): 91-104, 2000 Feb.
Article in English | MEDLINE | ID: mdl-10642037

ABSTRACT

Single enhancing CT lesions are the commonest radiological abnormality in Indian patients with new-onset partial seizures. In few patients the lesions may be 'tuberculoma' (especially in presence of evidence of tuberculosis elsewhere). However, histopathological studies have proved that neurocysticercosis is the most frequent cause for these lesions. Acute inflammation in and around the cerebral lesions of cysticercosis manifests as acute seizure disorder. These cysticercal granulomas represent 'colloidal' and 'nodular-granular' stages of Escobar's pathological classification of natural evolution of a parenchymal cysticercus cyst. In 8-12 weeks time majority of these lesions spontaneously disappear, few may calcify. As albendazole therapy is of controversial value, these patients, possibly, need to be treated only with antiepileptic drugs. Associated seizure disorder is also benign in nature and remit in majority within 6-8 months, recurrences are usually infrequent. Antiepileptic drug may be withdrawn once follow-up CT scan shows resolution of the lesion. If seizures recur after resolution of the lesion, CT lesion persists or CT lesion calcified, a long-term (2-3 years) antiepileptic therapy may be required. The single enhancing CT lesions which persist despite anticysticercal or antituberculous therapy may need histopathological evaluation to establish the correct diagnosis.


Subject(s)
Brain/diagnostic imaging , Calcinosis/diagnostic imaging , Epilepsies, Partial/diagnostic imaging , Granuloma/diagnostic imaging , Neurocysticercosis/diagnostic imaging , Seizures/diagnostic imaging , Tomography, X-Ray Computed , Tuberculoma, Intracranial/diagnostic imaging , Algorithms , Animals , Anthelmintics/therapeutic use , Antibodies, Bacterial/blood , Antibodies, Helminth/blood , Antibodies, Helminth/immunology , Anticonvulsants/therapeutic use , Antitubercular Agents/therapeutic use , Brain/parasitology , Calcinosis/complications , Child , Cysticercus/growth & development , Cysticercus/immunology , Cysticercus/isolation & purification , Diagnosis, Differential , Epilepsies, Partial/drug therapy , Epilepsies, Partial/etiology , Granuloma/epidemiology , Granuloma/etiology , Humans , India/epidemiology , Larva , Magnetic Resonance Imaging , Mycobacterium tuberculosis/immunology , Neurocysticercosis/complications , Neurocysticercosis/drug therapy , Neurocysticercosis/epidemiology , Prognosis , Recurrence , Seizures/drug therapy , Seizures/etiology , Tuberculoma, Intracranial/complications , Tuberculoma, Intracranial/drug therapy , Tuberculoma, Intracranial/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...